Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jonathan G. Seidman, Ph.D.

Co-Author

This page shows the publications co-authored by Jonathan Seidman and Sarah Morton.
Connection Strength

1.706
  1. Genomic frontiers in congenital heart disease. Nat Rev Cardiol. 2021 Jul 16.
    View in: PubMed
    Score: 0.244
  2. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease. JAMA Cardiol. 2021 Apr 01; 6(4):457-462.
    View in: PubMed
    Score: 0.239
  3. Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency. Circ Res. 2021 Apr 16; 128(8):1156-1169.
    View in: PubMed
    Score: 0.237
  4. Congenital Heart Defects Due to TAF1 Missense Variants. Circ Genom Precis Med. 2020 06; 13(3):e002843.
    View in: PubMed
    Score: 0.225
  5. Abnormal Left-Hemispheric Sulcal Patterns Correlate with Neurodevelopmental Outcomes in Subjects with Single Ventricular Congenital Heart Disease. Cereb Cortex. 2020 03 21; 30(2):476-487.
    View in: PubMed
    Score: 0.223
  6. Rare genetic variation at transcription factor binding sites modulates local DNA methylation profiles. PLoS Genet. 2020 11; 16(11):e1009189.
    View in: PubMed
    Score: 0.058
  7. GATA6 mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm. Elife. 2020 10 15; 9.
    View in: PubMed
    Score: 0.058
  8. De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease. Circ Genom Precis Med. 2020 08; 13(4):e002836.
    View in: PubMed
    Score: 0.057
  9. Genomic analyses implicate noncoding de novo variants in congenital heart disease. Nat Genet. 2020 08; 52(8):769-777.
    View in: PubMed
    Score: 0.057
  10. EM-mosaic detects mosaic point mutations that contribute to congenital heart disease. Genome Med. 2020 04 29; 12(1):42.
    View in: PubMed
    Score: 0.056
  11. ORE identifies extreme expression effects enriched for rare variants. Bioinformatics. 2019 10 15; 35(20):3906-3912.
    View in: PubMed
    Score: 0.054
  12. Paternal-age-related de novo mutations and risk for five disorders. Nat Commun. 2019 07 10; 10(1):3043.
    View in: PubMed
    Score: 0.053
  13. Response to Brodehl et al. Genet Med. 2019 05; 21(5):1248-1249.
    View in: PubMed
    Score: 0.050
  14. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy. Genet Med. 2019 03; 21(3):650-662.
    View in: PubMed
    Score: 0.049
  15. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017 Nov; 49(11):1593-1601.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.